A phase I-II clinical trial to assess the effect of HC-SVT-1001 in the surgical treatment of atrophic pseudarthrosis of long bones
Phase of Trial: Phase I/II
Latest Information Update: 09 Oct 2017
At a glance
- Drugs HC SVT-1001 (Primary)
- Indications Pseudoarthrosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors SALVAT
- 03 Oct 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 03 Oct 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 31 Mar 2014 New trial record